You may be trying to access this site from a secured browser on the server. Please enable scripts and reload this page.
Turn on more accessible mode
Turn off more accessible mode
Skip Ribbon Commands
Skip to main content
Turn off Animations
Turn on Animations
Sign In
{{'GLOBAL_MESSAGE_HEADLINE' | translate}}
{{'GLOBAL_MESSAGE_CHOOSE_LANG' | translate}}
en
日本語
中文
{{'GLOBAL_MESSAGE_OR' | translate}}
{{'GLOBAL_MESSAGE_SET_COUNTRY' | translate}}
{{'ELOQUA_BANNER_DECLINE_CONFIRM' | translate}}
{{'ELOQUA_BANNER_DECLINE_CONFIRM_CLOSE' | translate}}
{{'ELOQUA_BANNER_ACCEPT' | translate}}
{{'ELOQUA_BANNER_DECLINE' | translate}}
{{'MP_LVL1NAV_PRODUCTS_SERVICES' | translate}}
{{d.Title}}
{{psData[masterIndex].Blurb}}
{{s.Title}}
{{l.Title}}
{{n.Title}}
{{n.Blurb}}
{{s.Title}}
{{l.Title}}
Welcome, {{userName}}
{{'MP_HEADER_LOG_IN' | translate}}
{{countryCode}}
{{'SEARCH_MODAL_TITLE' | translate}}
{{'MP_LVL1NAV_PRODUCTS_SERVICES' | translate}}
{{c.Title}}
{{s.Title}}
{{l.Title}}
{{n.Title}}
{{s.Title}}
{{l.Title}}
Page Content
Terumo Blood and Cell Technologies and Charles River Demonstrate Versatility of FINIA Automated Cell and Gene Therapy Fill and Finish Platform.
Terumo Blood and Cell Technologies celebrates 60 years as a community-first Colorado company.
Help patients who need the healing power of blood and cells. Explore 60 ways to support blood donation.
Terumo BCT supports research about pregnancy with sickle cell disease
FDA Clears the Individualized Nomogram for Rika Plasma Donation System.
The Hidden Struggle: Confronting Sickle Cell Disease Health Inequalities. Read Terumo Blood and Cell Technologies' EU Sickle Cell Disease Manifesto.
QUICK LINKS
Get Product Support
Find Technical Documents
Find Certificates of Compliance
Get Training
Start a Career With Us
Distributor News
Modern Slavery Act Statement
Ethylene Oxide and Sterilization in Healthcare
LATEST NEWS
Terumo Blood and Cell Technologies and Charles River Demonstrate Versatility of FINIA Automated Cell and Gene Therapy Fill and Finish Platform
Terumo Blood and Cell Technologies celebrates 60 years as a community-first Colorado company
Terumo BCT supports research about pregnancy with sickle cell disease
Terumo Blood and Cell Technologies names Mani Venkatesh the VP of Digital Transformation.
FDA Clears the Individualized Nomogram for Rika Plasma Donation System.
The Hidden Struggle: Confronting Sickle Cell Disease Health Inequalities. Read Terumo Blood and Cell Technologies' EU Sickle Cell Disease Manifesto.
World-leading CiRA to integrate Quantum Flex to develop automated iPS cell manufacturing. Learn more
BioCentriq® presents first public CAR-T expansion data from Terumo Blood and Cell Technologies’ Quantum Flex Cell Expansion System
Terumo Blood and Cell Technologies-sponsored panel publishes first-of-its-kind international consensus recommendations for pregnancy complications in patients with sickle cell disease
Hundreds of sickle cell patients to benefit from £1.5M technology investment
{{'SEARCH_MODAL_TITLE' | translate }}
{{s.Query|stripSpecialChars}}
{{'SEARCH_MODAL_OR' | translate }}
{{'SEARCH_MODAL_BROWSE' | translate }}
{{'SEARCH_MODAL_ENLABEL' | translate }}
{{'SEARCH_MODAL_PRODUCT' | translate }}
{{productCode.RefinementName}}
{{'SEARCH_MODAL_CATEGORY' | translate }}
{{categoryCode.RefinementName}}
{{'SEARCH_SMODAL_SEGMENT' | translate }}
{{segmentCode.RefinementName}}
{{'SEARCH_MODAL_SHOW_BROWSE_RESULTS' | translate }}
{{'SEARCH_MODAL_CHOOSE_LANGUAGE' | translate }}
{{'SEARCH_MODAL_CHANGE_LANGUAGE' | translate }}
{{$index+1}}. {{s.label}}